The Pan UK Pharmacy Working Group (PWG) for ATMPs was established in 2018 to act as an expert and informed body to support the activities of UK Pharmacies to facilitate ATMP usage.
This new class of medicines have storage, reconstitution and handling procedures that are specific for each product which can require close collaboration with stem cell laboratory colleagues, as well as posing interesting challenges in clinical management often requiring complex toxicity management.
The group consists of pharmacists from across the UK that specialise in the governance, prescribing, administration and monitoring of ATMPs and is an excellent example of collaboration across the NHS. The aims of the group are to promote good practice, identify and resolve pharmacy issues to maximise the effectiveness and development of services for hospitals to administer advanced therapies.
Follow the links below to access the guidance
(Guidance is listed in order of publication date)
Regional QA Specialist Pharmacist, NHS SPS